0Suppliers
1Customers
3Debt Items
6Related Chains

Standard BioTools Inc. Suppliers

No suppliers on recordStandard BioTools Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Standard BioTools Inc. Customers

TickerNameConfidenceEvidence
ILLUMINA ILLUMINA 92% On January 30, 2026, the Company completed the sale of the Disposed Entities to Illumina pursuant to the Purchase Agreement.

Standard BioTools Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LAB-DEBT Debt stack $29.5M 90% Market cache reports total debt of $29.5M.
LAB-DEBT-10602 Warrants outstanding: -232000 90% xbrl warrant detail from xbrl 2025-12-31.
LAB-DEBT-10603 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Standard BioTools Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Standard BioTools Inc..

Standard BioTools Inc. Ownership

HolderNameConfidenceEvidence
LAB-OWNER-CASDIN-CAPITAL-LLC Casdin Capital, LLC 90% 13F overlay lists Casdin Capital, LLC as top holder; 155 tracked holders.

Standard BioTools Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BDX Becton, Dickinson and Company 100.00 2
AMGN Amgen Inc. 50.00 2
WAT Waters Corporation 50.00 2
AMGEN AMGEN 50.00 2
NAUT Nautilus Biotechnology, Inc. 42.84 1 ['spend']
CTKB Cytek Biosciences, Inc. 36.29 1 ['spend']